Potential of Tau Vaccine to Treat Alzheimer's | Brain Talk | Being Patient

Being Patient spoke with Norbert Žilka, chief scientific officer at AXON Neuroscience, about how abnormal tau proteins are linked to neurodegeneration and new therapeutic approaches that target the pathological proteins.

We rely on donations to bring you the latest research on dementia and brain health and to support our amazing team of independent journalists. Please consider donating to support of our mission of giving people impacted by dementia a better resource and connection to experts at the forefront of research. Our audience has grown so rapidly; we have exciting plans for the future to enhance our coverage even further but we need your help. Please consider making a contribution to help fund Being Patient's editorial costs.
https://beingpatient.nationbuilder.com/

---------------------------------------------------------------------------------------------------------------
Stay connected on social media:
To catch our Brain Talks live, join our Facebook page:
https://www.facebook.com/beingpatient...

To learn more about us, follow us on Instagram:
@beingpatientvoices

For the latest news on dementia research and lifestyle tips, visit our site:
https://www.beingpatient.com/

Видео Potential of Tau Vaccine to Treat Alzheimer's | Brain Talk | Being Patient канала Being Patient Alzheimer's